Home › Merck Demands $3 Billion In HCV Royalties From Gilead
 

Keywords :   


Merck Demands $3 Billion In HCV Royalties From Gilead

2016-03-11 20:20:18| Biotech - Topix.net

Merck wants to Bogart a $3B royalty payment equal to 10% of the $31.7B Gilead has made from HCV sales. Gilead has had a target on its back from regulators, competitors and politicians ever since its blockbuster HCV regimen hit the market.

Tags: billion demands merck royalties

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
20.05IMDA launches annual IMDA Awards Competition
20.05Registration opens for FTAs Fall Technical Conference 2024
20.05Voting begins for Colored By INX Can Design Contest
20.05New Study Highlights Biodegradability of Cotton and Cellulosic Microfibers
20.05New ACA-Published Industry Market Analysis for the Paint & Coatings Industry Now Available
20.05Ulta Beauty Launches Same-Day Delivery with DoorDash
20.05Nivea Crmes Limited-Edition Pride Tin Heralds New Initiative with PFLAG
20.05Sheboygan Paint Company Appoints New Technical Sales Representative
More »